AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie u.S. Retail Sales: Pharmacies and Drug Stores — Seasonally Adjusted ($M) ($M)
FRED (MRTSSM44611USS)
Latest, FY2025
404,092
Period ended Dec 31, 2025
Change on a year earlier
+8.9%
371,000 in FY2024
History
10 years
Since FY2016
Sources
1
FRED (MRTSSM44611USS)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Retail Sales: Pharmacies and Drug Stores — Seasonally Adjusted ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 404,092 | +8.9% | FRED (MRTSSM44611USS) ↗ |
| FY2024 | Dec 31, 2024 | 371,000 | +7.8% | FRED (MRTSSM44611USS) ↗ |
| FY2023 | Dec 31, 2023 | 344,003 | +6.4% | FRED (MRTSSM44611USS) ↗ |
| FY2022 | Dec 31, 2022 | 323,444 | +3.5% | FRED (MRTSSM44611USS) ↗ |
| FY2021 | Dec 31, 2021 | 312,501 | +6.3% | FRED (MRTSSM44611USS) ↗ |
| FY2020 | Dec 31, 2020 | 294,043 | +3.7% | FRED (MRTSSM44611USS) ↗ |
| FY2019 | Dec 31, 2019 | 283,422 | +2.4% | FRED (MRTSSM44611USS) ↗ |
| FY2018 | Dec 31, 2018 | 276,908 | +2.9% | FRED (MRTSSM44611USS) ↗ |
| FY2017 | Dec 31, 2017 | 269,172 | +2.7% | FRED (MRTSSM44611USS) ↗ |
| FY2016 | Dec 31, 2016 | 262,123 | – | FRED (MRTSSM44611USS) ↗ |
Breakdown
What makes up u.s. retail sales: pharmacies and drug stores — seasonally adjusted ($m)
Cite this data
StockData. (2026). AbbVie U.S. Retail Sales: Pharmacies and Drug Stores — Seasonally Adjusted ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fred_rx_retail_sa
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.